3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Suspended
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Lymphoid
6
Other hematologic neoplasm
5
Genitourinary
5
Gastrointestinal
2
Classical hematology
2
Plasma cell
1
Other
1
Myeloid
1
Dermatologic
1
Conditions
Colorectal Neoplasms
1432
Pancreatic Neoplasms
860
Carcinoma, Hepatocellular
743
Stomach Neoplasms
647
Colonic Neoplasms
447
Rectal Neoplasms
404
Esophageal Neoplasms
398
Breast Neoplasms
331
Carcinoma, Non-Small-Cell Lung
326
Neoplasms
307
Liver Neoplasms
282
Cholangiocarcinoma
244
Ovarian Neoplasms
243
Lung Neoplasms
237
Neoplasm Metastasis
235
Gastrointestinal Neoplasms
217
Melanoma
185
Prostatic Neoplasms
166
Esophageal Squamous Cell Carcinoma
166
Biliary Tract Neoplasms
161
Endometrial Neoplasms
143
Uterine Cervical Neoplasms
130
Squamous Cell Carcinoma of Head and Neck
129
Carcinoma, Renal Cell
114
Head and Neck Neoplasms
113
Sarcoma
100
Urinary Bladder Neoplasms
97
Adenocarcinoma Of Esophagus
90
Triple Negative Breast Neoplasms
86
Anus Neoplasms
83
Interventions
Surveys and Questionnaires
1
Phlebotomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Renal Insufficiency, Chronic
×
Gastrointestinal
×
1 year
×
Clear all
NCT05786482
2026-05-08
EMPOwer
University of Alberta
Phase NA
Completed
825 enrolled
NCT04306939
2026-01-07
GREAT1
University of Pittsburgh
Suspended
120,000 enrolled